A growing body of evidence supports the role of type 2 diabetes as an individual-level risk factor for tuberculosis (TB), though evidence from developing countries with the highest TB burdens is lacking. Agreement on how to screen, monitor and record the screening was reached in October 2011 at a national stakeholders’ meeting, and training was carried out for staff in the six tertiary care facilities in December 2011. The report comes just as global health experts are set to convene early next week to address TB and its relationship with another major disease that is rapidly increasing: diabetes. That number is expected to escalate to nearly 600 million people by 2035. However, patients under DOTS are not screened for diabetes before the therapy. Since the most recent systematic review, we are aware of seven more published analytical studies in humans looking at the question of TB risk associated with diabetes, including two case-control [26, 27] and five cohort studies [25, 28, 29, 4, 32] summarised in Additional file 5. “Diabetes among adult TB patients in the Pacific Islands is the rule, not the exception,” he said.
One person was diagnosed with active TB and started on anti-TB treatment. ‘Collaborative framework for care and control of TB and diabetes’, a document prepared by the WHO states that diabetes intensifies the risk of developing TB. Greater prevalence is seen in younger people, those with low body weight and type 1 diabetes. The long-term